DICE Therapeutics, Inc.
DICE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$83,887 | -$48,959 | -$23,739 | -$12,938 |
| Dep. & Amort. | $2,423 | $661 | $697 | $706 |
| Deferred Tax | $0 | $1,671 | $0 | $0 |
| Stock-Based Comp. | $12,825 | $5,581 | $556 | $529 |
| Change in WC | $2,643 | $1,647 | $1,663 | -$4,649 |
| Other Non-Cash | $1,674 | $107 | $144 | $54 |
| Operating Cash Flow | -$64,322 | -$39,292 | -$20,679 | -$16,298 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,237 | -$718 | -$148 | -$981 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$139,252 | -$218,471 | -$3,649 | -$39,775 |
| Inv. Sales/Matur. | $228,976 | $14,565 | $21,800 | $21,624 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $87,487 | -$204,624 | $18,003 | -$19,132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $323,710 | $214,707 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $322,252 | $300,254 | $53,895 | -$278 |
| Financing Cash Flow | $322,252 | $300,254 | $53,895 | -$278 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $345,417 | $56,338 | $51,219 | -$35,708 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116,174 | $59,836 | $8,617 | $44,325 |
| End Cash | $461,591 | $116,174 | $59,836 | $8,617 |
| Free Cash Flow | -$66,559 | -$40,010 | -$20,827 | -$17,279 |